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Abstract: A series of novel tetrabromo-bis(substituted benzyl)cycloalkanones 
have been synthesized through a rapid, simple, and efficient methodology in an 
excellent isolated yield and characterized via IR, NMR (1H-, 13C-NMR, DEPT 
135, DEPT 90) and mass spectrometry. All compounds were assayed for their 
in vitro antimicrobial activities against eight bacteria and five fungi. They showed 
stronger antibacterial than antifungal activities. Compounds 4c, 4d and 4i, con-
taining a methoxy or chloro substituent on the para or meta position of the phe-
nyl ring, showed comparable minimum inhibitory concentration (MIC) values 
to those of the standard antibiotics streptomycin and tetracycline. Among all 
the tested compounds, 4i exhibited good to moderate antifungal activity against 
all the tested fungal strains used. 
Keywords: antibacterial; antifungal; tetrabromo-bis-(substituted benzyl)cyclo-
alkanones. 
INTRODUCTION 
In the past few decades, the incidence of serious antimicrobial infection has 
increased dramatically1 due to the problem of multi-drug resistant microorga-
nisms that has reached alarming levels around the world. For the treatment of 
microbial infections, the synthesis of new anti-infectious compounds has become 
a critical need. The organohalogen compounds have received much attention due 
to their important use in the field of medicinal and agro-chemistry.2–4 A survey 
of the literature also revealed that different kinds of bis(substituted benzyli-
dene)cycloalkanones, including organohalogen compounds, have been used for 
the treatment of the central nervous system, cardiovascular and obesity diseases, 
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and also showed antibacterial,5 antifungal,5 anti-angiogenic,6,7 quinine reductase 
inducer,8 cytotoxic,9,10 and cholesterol-lowering activity.11  
In 1980, Hoeve and Wynberg12 prepared tetrabromo-di-m-anisalcyclopen-
tanone from 2,5-dibenzylidenecycloalkanones using bromine in chloroform in a 
47 % yield. Later, in 1988, Desiraju and Kishan13 used the same starting material 
and obtained dibromo derivatives in which the bromine addition occurred on the 
methylene carbon of 2,5-dibenzylidenecycloalkanones. In the present study, we 
have synthesized and performed antimicrobial evaluation of a series of tetra-
bromo-bis(substituted benzyl)cycloalkanone analogues (4a–j). The structures of 
the new compounds were established by IR, NMR (1H-, 13C-, DEPT 135 and 
DEPT 90) and mass spectrometry. 
EXPERIMENTAL 
Chemistry 
General. Melting points were recorded on a Fisher–Jones melting point apparatus and 
are uncorrected. IR spectra were obtained on an FTIR-300E (Jasco Corporation, Tokyo, Ja-
pan) in KBr disc. 1H-NMR (250 MHz) and 13C-NMR (62.5 MHz) spectra were recorded on a 
Bruker 250 spectrometer (Bruker, USA) in CDCl3 with TMS as an internal standard. ESI- 
-MS were measured on an LCQ advantage-trap mass spectrometer (Thermo Finnigan, San 
Jose, CA, USA). 
Synthesis of bis(substituted benzyl)cycloalkanones 3a–j 
The bis(substituted-benzyl)cycloalkanones were obtained by the cross-aldol condensa-
tion of substituted aldehydes with cycloalkanones in the presence of sodium acetate–acetic 
acid, Scheme 1.14 
Synthesis of tetrabromo-bis(substituted benzyl)cycloalkanones 4a–j 
The tetrabromo-bis(substituted benzyl)cycloalkanones (4a–j) were prepared by adding a 
Br2 solution (2 mmol) in dioxane (10 mL) dropwise over 10 min to a stirred solution of the 
respective bis(substituted benzyl)cycloalkanone (3a–j, 1 mmol) in dioxane (20 mL). The stirring 
was continued for 3–4 h. The completion of the reaction was monitored by thin layer chroma-
tography (TLC). The solvent was evaporated and the dry residue subjected to column chroma-
tography (n-hexane/dichloromethane, 1:1), which afforded the respective compound 4a–j as a 
white solid. 
Data of synthesized compounds are given in Supplementary material. 
Biology 
Antibacterial screening. The in vitro antibacterial activity of the synthesized compounds 
4a–j were evaluated against eight bacterial strains, i.e., Staphylococcus aureus (KCTC 1916), 
Bacillus subtilis (ATCC 6633), Listeria monocytogenes (ATCC 19166), Salmonella enteritidis 
(KCCM 12021), Pseudomonas aeruginosa (KCTC 2004), Enterobacter aerogenes (KCTC 
2190), Salmonella typhimurium (KCTC 2515) and Escherichia coli (ATCC 8739). All the 
bacterial strains were obtained from the Korea Food and Drug Administration (KFDA), 
Daegu, South Korea. Cultures of each bacterial strain were maintained on Luria broth (LB) 
agar medium at 4 °C. 
The minimum inhibitory concentrations (MICs) of compounds 4a–j were tested by the 
two-fold serial dilution method.15 The test compounds 4a–j were incorporated into Luria– 
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–Broth medium to obtain a concentration of 1,000 μg ml-1 and serially diluted to a concen-
tration in the range from 500 to 7.8 μg ml-1. A standardized suspension (10 μl) of each of the 
tested organism (108 CFU ml-1) was transferred to each tube and incubated at 37 °C for 24 h. 
Control tubes containing only bacterial suspensions were also incubated at 37 °C for 24 h. The 
lowest concentrations of the test samples that did not show any growth of the tested organism 
after macroscopic evaluation were determined as the MICs. 
 
      
Compound  n  R1 R 2 
3a, 4a  1 H H 
3b, 4b  1 H  CH3 
3c, 4c  1 Cl H 
3d, 4d  1 H  OCH3 
3e, 4e  1 H F 
3f, 4f  2 H H 
3g, 4g  2 H  CH3 
3h, 4h  2 H F 
3i, 4i  2 H  OCH3 
3j, 4j  2 H  Br 
     
Scheme 1. Reagents and conditions: a) AcONa, AcOH, 3–8 h, 120 °C; 
b) Br2–dioxane, 3–4 h, room temperature. 
Antifungal screening. The in vitro antifungal activities of the synthesized compounds 4a–j 
were evaluated against various fungal species, i.e., Botrytis cinerea (KACC 40573), Rhizoc-
tonia solani (KACC 40111), Fusarium oxysporum (KACC 41083), Sclerotonia sclerotiorum 
(KACC 41065) and Phytophthora capsici (KACC 40157). The fungal cultures were obtained 
from the Korean Agricultural Culture Collection (KACC). Cultures of each fungal species 
were maintained on potato dextrose agar (PDA) slants and stored at 4 °C. 
Potato dextrose agar (PDA) medium was used as the basal medium for the antifungal 
activity assay, which was performed by disc diffusion method.16 Sterile Whatman No. 1 paper 
discs (6 mm diameter) were pierced in agar plates, equidistant and near the border, where 10 
μl of compounds 4a–j (200 μg disc-1) were applied. A disc of fungal inoculum 6 mm in dia-
meter was removed from the pre-grown cultures of all the tested fungal strains and placed 
upside down in the center of the Petri dishes. The plates were incubated at 28 °C for 5–7 days, 
the time in which the growth of the control would have reached the edges of the plates. Discs 
with CHCl3 and nystatin were used as negative and positive controls, respectively. The in-
hibitory activity was measured (in mm) as the diameter of the observed inhibition zones. 
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The minimum inhibitory concentration (MIC) was determined by the two-fold dilution 
method,15 against B. cinerea, R. solani, F. oxysporum, S. sclerotiorum and P. capsici. Samples 
were dissolved in CHCl3 accordingly with their respective known weight. These solutions 
were serially diluted with CHCl3 and were added to PDA to final concentrations of 500, 250 
125 and 62.5, 31.2, 15.6 and 7.8 μg ml-1, respectively. A 10 μl spore suspension of each test 
strain was inoculated in test tubes in PDA medium and incubated for 2–7 days at 28 °C. The 
control tubes containing PDA medium were inoculated only with fungal suspension. The mi-
nimum concentration at which no visible growth was observed was defined as the MIC, which 
was expressed in μg ml-1. 
RESULTS AND DISCUSSION 
Chemistry 
The synthetic route to the tetrabromo-bis(substituted benzyl)cycloalkanones 
(4a–j) are outlined in Scheme 1. The compounds 4a–j were obtained from the 
intermediate compounds 3a–j, respectively, in excellent yields (70–93 %). The 
structures of the newly synthesized compounds were established based on their 
IR, 1H-NMR, 13C-NMR, DEPT 135, DEPT 90 and mass spectral data. IR spectra 
of compounds 4a–j showed an absorption peak in the 1660–1681 cm–1 region, 
indicating the presence of a carbonyl (>C=O) group. In the 1H-NMR spectra, the 
characteristic benzylic protons of compounds 4a–j appeared as a singlet at 5.50– 
–6.03 ppm. The aliphatic protons of the cyclopentanone ring of compounds 4a–e 
appeared as two AB-quartets at around 3.28–3.32 and 2.37–2.42 ppm equivalent 
to two protons, respectively. On the other hand, the six protons of the cyclohexa-
none ring of compounds 4f–j were observed as triplets of a doublet at 2.99–3.07 
ppm and two multiplets at around 2.14–2.46 and 1.90–2.03 ppm equivalent to 
two, three and one proton(s), respectively. The aromatic protons of the phenyl 
groups of compounds 4a–j appeared in usual way. The methyl protons of com-
pounds 4b and 4g were observed as a singlet at 2.35–2.36 ppm, whereas the me-
thoxy protons of compounds 4d and 4i appeared as a singlet at 3.81–3.82 ppm. In 
the 13C-NMR spectra of compounds 4a–j, the characteristics carbonyl carbons 
and benzylic carbons appeared at 197.77–198.57 ppm and 51.40–55.30 ppm, 
respectively. In addition, the α-carbons were observed in the range of 63.95– 
–67.98 ppm. In summary, all the newly synthesized compounds exhibited satis-
factory spectral data consistent with the proposed structures. In addition, electron 
spray ionization mass spectra (ESI-MS) of 4a–j showed a metastable ion peak as 
[M(79Br)+H]+ (100 %) in the positive mode along with other isotopic peaks.  
Antibacterial activity 
The in vitro antibacterial activities of the novel compounds 4a–j were as-
sayed against three Gram-positive bacteria viz. S. aureus, B. subtilis and L. mo-
nocytogenes and five Gram-negative bacteria, viz. S. enteritidis, P. aeruginosa, 
E. aerogenes, S. typhimurium and E. coli. The minimum inhibitory concentration 
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(MIC / μg ml–1) was determined by the serial dilution method15 for all the com-
pounds and compared with the controls (streptomycin and tetracycline). The MIC 
values of the tested compounds are presented in Table I, from which it can be 
seen that all the tetrabromo-bis-benzylcycloalkanone analogues (4a–j) showed 
antibacterial activity against both the Gram-positive and Gram-negative bacteria. 
Among the tested compounds, compound 4i exhibited the highest activity against 
both Gram-positive and Gram-negative strains, followed by compounds 4c and 
4d. The MIC values of compounds 4i, 4c and 4d are almost comparable to those 
of the standard drugs used in the present study against all bacterial strains. 
TABLE I. Antibacterial activity (MIC / μg ml-1) of compounds 4a–j 
Compound  S. au- 
reus 
B. sub-
tilis 
L. mono-
cytogenes
S. enteri-
tidis 
P. aeru-
ginosa 
E. aero-
genes 
S. typhi-
murium  E. coli 
4a  125 125 125 125 125 125 62.5  62.5 
4b  62.5 62.5 31.2 62.5 125 62.5 62.5 125 
4c  31.2 15.6 31.2 15.6 31.2 15.6 31.2 15.6 
4d  31.2 15.6 32.2 15.6 31.2 15.6 31.2 31.2 
4e  31.2 31.2 31.2 62.5 62.5 31.2 31.2 31.2 
4f  62.5 125 62.5 125 62.5 62.5 125 125 
4g  62.5 62.5 62.5 62.5 62.5 125 62.5 32.2 
4h  31.2 62.5 62.5 62.5 62.5 62.5 31.2 31.2 
4i  31.2 15.6 31.2 15.6 31.2 15.6 15.6 15.6 
4j  62.5 62.5 31.2 31.2 62.5 31.2 31.2 31.2 
Streptomycin 31.2 15.6 31.2 31.2 31.2 15.6 31.2 15.6 
Tetracycline
  15.6 15.6 31.2 15.6 31.2 15.6 15.6 15.6 
Structure–activity relationships (SAR) may be explained briefly as follows: 
the ring size of cycloalkanones has no strong effect on the antibacterial activity, 
whereas the unsubstituted compounds (4a and 4f) showed lower activity than the 
substituted compounds (4b–d and 4g–j). Introduction of hydrophilic substituents 
(halogen, OMe) at the R2 or R1 position resulted in better activity than the hydro-
phobic substituent (CH3). Among the compounds containing halogen substitution 
at the phenyl ring, the chlorine analogue (4c) showed better antibacterial activity 
than the fluorine or bromine analogues (4e, 4h and 4j). 
Antifungal activity 
The newly synthesized novel 4a–j were evaluated for their in vitro antifungal 
activities against five fungal strains, i.e., B. cinerea, R. solani, F. oxysporum, S. 
sclerotiorum and P. capsici by disc diffusion methods. The inhibition zones of the 
synthesized compounds were measured at a dose of 200 μg disc–1 and nystatin, a 
positive control, were evaluated at a dose of 30 μg disc–1. As presented in Table 
II, among the all tetrabromo-bis-benzylcycloalkanone derivatives (4a–j) tested, 5 
compounds inhibited the growth of some fungal strains. In detail, compound 4i 
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showed good to moderate activity against all the tested fungal strains, while 
compounds 4d and 4j exhibited moderate activity against R. solani and F. oxy-
sporum. Compounds 4f and 4h demonstrated moderate activity against one bac-
terial strain only. Compounds 4a–c, 4e and 4g showed no activity against all the 
tested fungal strains. Therefore, the minimum inhibitory concentrations (MICs) of 
compound only 4i against B. cinerea, R. solani, F. oxysporum, S. sclerotiorum, 
and P. capsici were determined and found MIC values of 125, 31.2, 31.2, 125 
and 250 µg ml–1, respectively, were found (Table III). 
TABLE II. Antifungal profile of compounds 4a–j in terms of the inhibition zone in mm (data 
are means ± SD for at least three experiments. Concentrations of compounds 4a–j and netil-
mycin were 200 and 30 μg disc-1, respectively) 
Compound  B. cinerea  R. solani  F. oxysporum  S. sclerotiorum  P. capsici 
4d  – 08±1.1 10±1.1  –  – 
4f  – 09±1.1  –  –  – 
4h  – – 07±1.1  –  – 
4i  07±1.2 19±1.0  19±1.1  08±1.1  07±1.0 
4j  – 11±1.1 11±1.2  –  – 
Nystatin 23±1.1  25±1.2  25±1.1  27±1.1 33±1.0 
TABLE III. Antifungal activity (MIC / μg ml-1) of compound 4i 
Compound  B. cinerea  R. solani  F. oxysporum  S. sclerotiorum  P. capsici 
4i  125 31.2  31.2  125  250 
Nystatin 15.6  15.6 15.6  31.2  30.2 
CONCLUSIONS 
In this paper, an efficient synthesis of novel tetrabromo-bis(substituted 
benzyl)cycloalkanone derivatives and their antimicrobial activities against eight 
bacterial and five fungal strains were presented. All the tetrabromo-bis(substi-
tuted benzyl)cycloalkanone analogues showed potent antibacterial activity com-
pared to their antifungal activity. Compounds 4i, 4c and 4d, having a methoxy- or 
chloro-substituent on the para or meta position of the phenyl ring exhibited 
strong activity against all the tested bacterial strains. Hydrophilic substitution on 
the phenyl ring resulted in a better antibacterial activity than that of hydrophobic 
substitution. Among all the tested compounds, 4i exhibited good antifungal ac-
tivity against R. solani and F. oxysporum. The potential antimicrobial activity of 
compounds 4i, 4c and 4d would be helpful in synthesis of a huge number of 
tetrabromo-bis(substituted benzyl)cycloalkanone analogues for extensive anti-
microbial studies, which could be used to develop more suitable drug candidates. 
SUPPLEMENTARY MATERIAL 
Аnalytical and spectral data of synthesized compounds are available electronically from 
http://www.shd.org.rs/JSCS/, or from the corresponding author on request. 
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ИЗВОД 
СИНТЕЗА И АНТИМИКРОБНА АКТИВНОСТ НОВИХ 
ТЕТРАБРОМ-БИС(СУПСТИТУИСАНИХ БЕНЗИЛ)ЦИКЛОАЛКАНОНА 
A. F. M. MOTIUR RAHMAN
1, MOHAMMAD SAYED ALAM,
2,3 и ADNAN A. KADI
1 
1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi 
Arabia, 2Division of Bioscience, Dongguk University, Geyonju 780–714, Republic of Korea и 
3Department of Chemistry, Jagannath Univeristy, Dhaka 1100, Bangladesh 
Синтетисана  је  серија  нових  тетрабром-бис(супституисаних  бензил)циклоалканона, 
брзим и ефикасним поступком. Производи су добијени у високом приносу и окарактерисани 
су спектроскопским методама (ИЦ, NMR (1H-, 13C-NMR, DEPT 135, DEPT 90)) и масеном 
спектрометријом.  Испитана  је  in vitro  антимикробна  активност  синтетисаних  једињења 
према осам врста бактерија и 5 врста гљива. Тестирана једињења показују добру антибак-
теријску и антифунгалну активност. Једињења 4c, 4d and 4i која садрже метокси- и хлор- 
-супституенте у para и meta положају на фенил групи имају вредности MIC које су блиске 
вредностима које дају стандардни антибиотици стрептомицин и тетрациклин. Од свих испи-
тиваних једињења, дериват 4i показује добру до умерену активност према све четири врсте 
гљива. 
(Примљено 8. априла 2011, ревидирано 6. јануара 2012) 
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